Skip to main content

Table 2 The marine-derived extracts or compounds with in vitro anti-neuroinflammatory activity

From: Marine-derived protein kinase inhibitors for neuroinflammatory diseases

Extracts or compounds

Marine source

Therapeutic area

Possible molecular pathway

Methanol extracts

Marine green algae

Ulva conglobata

Neuroinflammation

Inhibition of iNOS and COX-2 [77]

Alginate-derived oligosaccharide

Various brown algae

AD

Inactivation the TLR4-NF-κB signaling pathway [78]

Dieckol

Brown algae

Ecklonia cava

Neuroinflammation

Downregulation of ERK, Akt and NADPH oxidase-mediated pathways [79]

Floridoside

Red algae

Laurencia undulata

Neuroinflammation

Inhibition of p38 and ERK [80]

Phlorofucofuroeckol B

Brown algae

Ecklonia stolonifera

Neuroinflammation

Inhibition of IκB-alpha/NF-κB and Akt/ERK/JNK pathways [81]

Aurantiamide acetate

Marine fungus

Aspergillus sp. SF-5921

Neuroinflammation

Inhibition of NF-κB, JNK, and p38 [82]

Citreohybridonol

Marine fungus

Toxicocladosporium sp. SF-5699

Neuroinflammation

Inhibitory effect on the NF-κB and p38 pathways [83]

Sinuleptolide

Soft coral

Sinularia kavarattiensis

Neuroinflammation

Inhibition of IL-1β, IL-6, IL-8, IL-18, and TNF-α [84]

  1. AD Alzheimer disease, COX-2 cyclooxygenase-2, ERK extracellular signal-regulated kinase, IκB inhibitor of NF-κB, IL interleukin, iNOS inducible nitric oxide synthase, JNK c-Jun N-terminal kinase, NADPH nicotinamide adenine dinuclelotide phosphate, NF-κB nuclear factor κB, TLR4 toll-like receptor 4, TNF-α tumor necrosis factor-α